VAERS reports by lot

GSK Flu lot A3AD2: VAERS reports

24 VAERS reports list lot A3AD2 as a GSK Flu vaccine, received between 2016-09-21 and 2018-01-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
17%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1822%
Neurological1518%
Musculoskeletal1215%
General / Systemic (non-local)1113%
Dermatological (non-injection-site)79%
Gastrointestinal67%
Cardiac / Cardiovascular56%
Respiratory34%
Autoimmune / Immune-mediated22%
Allergic / Anaphylactic22%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
New York4
New Jersey2
Virginia2
Maryland2
Massachusetts2
Vermont1
South Carolina1
Illinois1
Utah1
North Carolina1
Mississippi1

Reports by month received

2016-093
2016-105
2016-118
2016-124
2017-021
2017-031
2017-111
2018-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.